Sohn Seil, Kim Jinhee, Chung Chun Kee, Lee Na Rae, Sohn Moon Jun, Kim Sung Hwan
Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
Neuroscience Research Institute, Seoul National University Medical Research Center, Seoul, Korea.
J Korean Neurosurg Soc. 2017 Mar;60(2):195-204. doi: 10.3340/jkns.2016.0505.011. Epub 2017 Mar 1.
This 2009-2011 nation-wide study of adult Koreans was aimed to provide characteristics, medical utilization states, and survival rates for newly diagnosed patients with primary nonmalignant and malignant spine tumors.
Data for patients with primary spine tumors were selected from the Korean Health Insurance Review and Assessment Service database. The data included their age, sex, health insurance type, co-morbidities, medical cost, and hospital stay duration. Hospital stay duration and medical costs per person occurring in one calendar year were used. In addition, survival rates of patients with primary malignant spine tumors were evaluated.
The incidence rate of a primary spine tumor increased with age, and the year of diagnosis (≤0.0001). Average annual medical costs ranged from 1627 USD (pelvis & sacrum & coccyx tumors) to 6601 USD (spinal cord tumor) for primary nonmalignant spine tumor and from 12137 USD (spinal meningomas) to 20825 USD (pelvis & sacrum & coccyx tumors) for a primary malignant spine tumor. Overall survival rates for those with a primary malignant spine tumor were 87.0%, 75.3%, and 70.6% at 3, 12, and 24 months, respectively. The Cox regression model results showed that male sex, medicare insurance were significantly positive factors affecting survival after a diagnosis of primary malignant spine tumor.
Our study provides a detailed view of the characteristics, medical utilization states, and survival rates of patients newly diagnosed with primary spine tumors in Korea.
这项针对韩国成年人的2009 - 2011年全国性研究旨在提供新诊断的原发性非恶性和恶性脊柱肿瘤患者的特征、医疗利用状况及生存率。
从韩国健康保险审查与评估服务数据库中选取原发性脊柱肿瘤患者的数据。数据包括他们的年龄、性别、健康保险类型、合并症、医疗费用及住院时长。使用的是一个日历年内每人的住院时长和医疗费用。此外，还评估了原发性恶性脊柱肿瘤患者的生存率。
原发性脊柱肿瘤的发病率随年龄及诊断年份增加（≤0.0001）。原发性非恶性脊柱肿瘤的年均医疗费用从1627美元（骨盆、骶骨及尾骨肿瘤）到6601美元（脊髓肿瘤）不等，原发性恶性脊柱肿瘤的年均医疗费用从12137美元（脊膜瘤）到20825美元（骨盆、骶骨及尾骨肿瘤）不等。原发性恶性脊柱肿瘤患者在3个月、12个月和24个月时的总生存率分别为87.0%、75.3%和70.6%。Cox回归模型结果显示，男性及医疗保险是影响原发性恶性脊柱肿瘤诊断后生存的显著正向因素。
我们的研究详细呈现了韩国新诊断的原发性脊柱肿瘤患者的特征、医疗利用状况及生存率。
